Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Smid

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Breast (Edinburgh, Scotland)|March 21, 2026
A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancerNadine S van den Ende, Marcel Smid, John W M Martens, et al.
Gynecologic Oncology|February 6, 2010
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big pictureJozien Helleman, Marcel Smid, Maurice P H M Jansen, et al.
Cancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.
Breast Cancer Research : BCR|September 13, 2012
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genesMuhammad Riaz, Anieta M Sieuwerts, Maxime P Look, et al.
Breast Cancer Research and Treatment|July 16, 2010
Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypesMarcel Smid, Marlous Hoes, Anieta M Sieuwerts, et al.
NPJ Breast Cancer|May 12, 2026
Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventionsNadine S van den Ende, Marcel Smid, John W M Martens, et al.
Oncotarget|April 16, 2016
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosisMarjolein J A Weerts, Anieta M Sieuwerts, Marcel Smid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Genes associated with breast cancer metastatic to boneMarcel Smid, Yixin Wang, Jan G M Klijn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 12, 2018
Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutationsMilea J M Timbergen, Matthijs L Janssen, Cornelis Verhoef, et al.
Cancer Research|May 3, 2008
Subtypes of breast cancer show preferential site of relapseMarcel Smid, Yixin Wang, Yi Zhang, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Breast (Edinburgh, Scotland)|March 21, 2026
A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancerNadine S van den Ende, Marcel Smid, John W M Martens, et al.
Gynecologic Oncology|February 6, 2010
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big pictureJozien Helleman, Marcel Smid, Maurice P H M Jansen, et al.
Cancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.
Breast Cancer Research : BCR|September 13, 2012
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genesMuhammad Riaz, Anieta M Sieuwerts, Maxime P Look, et al.
Breast Cancer Research and Treatment|July 16, 2010
Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypesMarcel Smid, Marlous Hoes, Anieta M Sieuwerts, et al.
NPJ Breast Cancer|May 12, 2026
Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventionsNadine S van den Ende, Marcel Smid, John W M Martens, et al.
Oncotarget|April 16, 2016
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosisMarjolein J A Weerts, Anieta M Sieuwerts, Marcel Smid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Genes associated with breast cancer metastatic to boneMarcel Smid, Yixin Wang, Jan G M Klijn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 12, 2018
Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutationsMilea J M Timbergen, Matthijs L Janssen, Cornelis Verhoef, et al.
Cancer Research|May 3, 2008
Subtypes of breast cancer show preferential site of relapseMarcel Smid, Yixin Wang, Yi Zhang, et al.
Pageof 13